These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 21546295)

  • 41. Elimination of the need for urine studies in the screening algorithm for monoclonal gammopathies by using serum immunofixation and free light chain assays.
    Katzmann JA; Dispenzieri A; Kyle RA; Snyder MR; Plevak MF; Larson DR; Abraham RS; Lust JA; Melton LJ; Rajkumar SV
    Mayo Clin Proc; 2006 Dec; 81(12):1575-8. PubMed ID: 17165636
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Potential pitfalls of serum free light chain analysis to assess treatment response for multiple myeloma.
    Abbi KK; Silverman M; Farooq U; Tricot A; Dozeman L; Nadiminti K; Krasowski MD; Tricot GJ
    Br J Haematol; 2016 Aug; 174(4):536-40. PubMed ID: 27172326
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Analytical performance of serum free light-chain assay during monitoring of patients with monoclonal light-chain diseases.
    Tate JR; Mollee P; Dimeski G; Carter AC; Gill D
    Clin Chim Acta; 2007 Feb; 376(1-2):30-6. PubMed ID: 16945362
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Serum free light chain immunoassay as an adjunct to serum protein electrophoresis and immunofixation electrophoresis in the detection of multiple myeloma and other B-cell malignancies.
    Harding SJ; Mead GP; Bradwell AR; Berard AM
    Clin Chem Lab Med; 2009; 47(3):302-4. PubMed ID: 19676141
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Combined analysis using extended renal reference range of serum free light chain ratio and serum protein electrophoresis improves the diagnostic accuracy of multiple myeloma in renal insufficiency.
    Park JW; Kim YK; Bae EH; Ma SK; Kim SW
    Clin Biochem; 2012 Jul; 45(10-11):740-4. PubMed ID: 22503879
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Neurologic sequelae of bone changes in multiple myeloma and its therapy].
    Basić-kes V; Basić-Jukić N; Kes P; Demarin V; Labar B
    Acta Med Croatica; 2002; 56(3):103-7. PubMed ID: 12630341
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Serum free light chains: diagnostic and prognostic value in multiple myeloma.
    Sthaneshwar P; Nadarajan V; Maniam JA; Nordin N; Gin Gin G
    Clin Chem Lab Med; 2009; 47(9):1101-7. PubMed ID: 19728852
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Immunoglobulin free light chain ratio is an independent risk factor for progression of smoldering (asymptomatic) multiple myeloma.
    Dispenzieri A; Kyle RA; Katzmann JA; Therneau TM; Larson D; Benson J; Clark RJ; Melton LJ; Gertz MA; Kumar SK; Fonseca R; Jelinek DF; Rajkumar SV
    Blood; 2008 Jan; 111(2):785-9. PubMed ID: 17942755
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Non-secretary multiple myeloma in a young Ethiopian: case report.
    Teklesilassie H; Sherif A; Diro E
    Ethiop Med J; 2010 Apr; 48(2):165-8. PubMed ID: 20608020
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [A case of non-secretory myeloma with crystal-storing histiocytosis].
    Park SH; Ahn JY; Seo YH; Park PH; Kim KH; Song YH; Jeong JH; Lee JH
    Korean J Lab Med; 2010 Dec; 30(6):580-4. PubMed ID: 21157142
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The predictive power of serum kappa/lambda ratios for discrimination between monoclonal gammopathy of undetermined significance and multiple myeloma.
    Bergón E; Miravalles E; Bergón E; Miranda I; Bergón M
    Clin Chem Lab Med; 2005; 43(1):32-7. PubMed ID: 15653439
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Serum free light chain (FLC) measurement can aid capillary zone electrophoresis in detecting subtle FLC-producing M proteins.
    Bakshi NA; Gulbranson R; Garstka D; Bradwell AR; Keren DF
    Am J Clin Pathol; 2005 Aug; 124(2):214-8. PubMed ID: 16040291
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Interlaboratory study of free monoclonal immunoglobulin light chain quantification.
    Vávrová J; Maisnar V; Tichý M; Friedecký B; Čermáková Z; Dastych M; Gottwaldová J; Kučera P; Krotká J; Racek J; Ženková J; Schneiderka P; Lochman P; Zima T; Benáková H; Büchler T; Spáčilová J; Hájek R; Palička V
    Clin Chem Lab Med; 2011 Jan; 49(1):89-92. PubMed ID: 21034251
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Analysis of Multiple Bands on Serum Protein Immunofixation Electrophoresis: Challenge in Interpretation of Clonality in a Patient with Light Chain-Predominant Multiple Myeloma.
    Nwogbo OV; Jin Y; Sliker T; Wilhite D; Singh G
    Lab Med; 2021 Sep; 52(5):503-508. PubMed ID: 33693845
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Complementarily of urine analysis and serum free light chain assay for assessing response treatment response: illustrated by three case examples.
    Levinson SS
    Clin Chim Acta; 2011 Nov; 412(23-24):2206-10. PubMed ID: 21864518
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Laboratory tools for oligo-secretory myeloma diagnosis: capillary electrophoresis versus free light chain assay.
    Cho SY; You E; Lee WI; Lee J; Lee HJ; Yoon HJ; Park TS
    Clin Lab; 2013; 59(3-4):445-8. PubMed ID: 23724639
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Polyclonal free light chain of Ig may interfere with interpretation of monoclonal free light chain κ/λ ratio.
    Levinson SS
    Ann Clin Lab Sci; 2010; 40(4):348-53. PubMed ID: 20947809
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Detection of free light chains--a new method of diagnostics of haematological diseases].
    Mecl J; Benáková H; Nohejlová A; Straub J; Zima T; Spicka I
    Cas Lek Cesk; 2007; 146(2):159-62. PubMed ID: 17373113
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Clinical significance of measurement of free light chains].
    Matsuda M
    Rinsho Byori; 2010 Apr; 58(4):401-4. PubMed ID: 20496770
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Serum free light-chain assay for nonsecretory multiple myeloma with light chain cast nephropathy and light chain deposition disease].
    Honma R; Fukase S; Suzuki M; Omoto E
    Rinsho Ketsueki; 2010 Apr; 51(4):270-4. PubMed ID: 20467224
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.